Login to Your Account



Financings Roundup


Thursday, November 3, 2011

• Access Pharmaceuticals Inc., of Dallas, entered definitive agreements with institutional and other investors for the private placement of $5.2 million of units consisting of Access common stock and warrants. Each unit consists of one share of Access common stock at $1.45 per share, with 50 percent warrant coverage with an exercise price of $1.67 per share and a term of 30 months and 50 percent warrant coverage with an exercise price of $2 per share and a term of five years. The transaction is expected to close on or about Nov. 7.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription